The research team identified, for the first time, a small-molecule inhibitor of the m6A methylase METTL3 in the body, STM2457, and confirmed that this inhibitor effectively inhibits the development of acute myeloid leukemia (AML) [39]. The gene discussed is METTL3; the disease is acute myeloid leukemia.